147 related articles for article (PubMed ID: 31612016)
1. Inhibition of long non-coding RNA-AWPPH decreases osteosarcoma cell proliferation, migration and invasion.
Ding W; Wu D; Ji F; Zhang H
Oncol Lett; 2019 Nov; 18(5):5055-5062. PubMed ID: 31612016
[TBL] [Abstract][Full Text] [Related]
2. LncRNA AWPPH promotes osteosarcoma progression via activation of Wnt/β-catenin pathway through modulating miR-93-3p/FZD7 axis.
Li C; Wang F; Wei B; Wang L; Kong D
Biochem Biophys Res Commun; 2019 Jun; 514(3):1017-1022. PubMed ID: 31092328
[TBL] [Abstract][Full Text] [Related]
3. LncRNA AWPPH promotes the proliferation, migration and invasion of ovarian carcinoma cells via activation of the Wnt/β‑catenin signaling pathway.
Yu G; Wang W; Deng J; Dong S
Mol Med Rep; 2019 May; 19(5):3615-3621. PubMed ID: 30896797
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of lncRNA AWPPH inhibits colon cancer cell proliferation by downregulating GLUT-1.
Bai J; Xu J; Zhao J; Zhang R
Oncol Lett; 2019 Aug; 18(2):2007-2012. PubMed ID: 31423271
[TBL] [Abstract][Full Text] [Related]
6. lncRNA AWPPH promotes the migration and invasion of glioma cells by activating the TGF-β pathway.
Dai B; Xiao Z; Mao B; Zhu G; Huang H; Guan F; Su H; Lin Z; Peng W; Hu Z
Oncol Lett; 2019 Dec; 18(6):5923-5929. PubMed ID: 31788066
[TBL] [Abstract][Full Text] [Related]
7. LncRNA AWPPH participates in the metastasis of non-small cell lung cancer by upregulating TGF-β1 expression.
Huo Y; Li A; Wang Z
Oncol Lett; 2019 Oct; 18(4):4246-4252. PubMed ID: 31516619
[TBL] [Abstract][Full Text] [Related]
8. LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate bladder cancer progression.
Zhu F; Zhang X; Yu Q; Han G; Diao F; Wu C; Zhang Y
J Cell Biochem; 2018 Jun; 119(6):4496-4505. PubMed ID: 29231261
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA AWPPH interacts with ROCK2 and regulates the proliferation and apoptosis of cancer cells in pediatric T-cell acute lymphoblastic leukemia.
Li X; Song F; Sun H
Oncol Lett; 2020 Nov; 20(5):239. PubMed ID: 32973953
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-AWPPH activates TGF-β1 in colorectal adenocarcinoma.
Liu C; Han B; Xin J; Yang C
Oncol Lett; 2019 Nov; 18(5):4719-4725. PubMed ID: 31611981
[TBL] [Abstract][Full Text] [Related]
12. LncRNA AWPPH promotes the invasion and migration of glioma cells through the upregulation of HIF1α.
Zhang T; Wang F; Liao Y; Yuan L; Zhang B
Oncol Lett; 2019 Dec; 18(6):6781-6786. PubMed ID: 31807187
[TBL] [Abstract][Full Text] [Related]
13. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
Ye F; Tian L; Zhou Q; Feng D
Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
[TBL] [Abstract][Full Text] [Related]
14. Long Non-Coding RNA AWPPH Promotes Postoperative Distant Recurrence in Resected Non-Small Cell Lung Cancer by Upregulating Transforming Growth Factor beta 1 (TGF-β1).
Tang L; Wang T; Zhang Y; Zhang J; Zhao H; Wang H; Wu Y; Liu K
Med Sci Monit; 2019 Apr; 25():2535-2541. PubMed ID: 30953582
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA GASL1 inhibits proliferation and invasion of osteosarcoma cells via modulation of the PI3K/Akt pathway.
Gao F; Xu F
Arch Med Sci; 2023; 19(3):717-723. PubMed ID: 37313212
[TBL] [Abstract][Full Text] [Related]
16. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
He R; Wu JX; Zhang Y; Che H; Yang L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
18. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
[TBL] [Abstract][Full Text] [Related]
19. lncRNA AWPPH promotes proliferation and inhibits apoptosis of non‑small cell lung cancer cells by activating the Wnt/β‑catenin signaling pathway.
Song Z; Du J; Zhou L; Sun B
Mol Med Rep; 2019 May; 19(5):4425-4432. PubMed ID: 30942396
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway.
Hu B; Lv X; Gao F; Chen S; Wang S; Qing X; Liu J; Wang B; Shao Z
Onco Targets Ther; 2017; 10():4379-4391. PubMed ID: 28932123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
